NF2-_MN621 drug treatment.xlsx

syn30384721

Created By Roberta Beauchamp Beauchamp

Uuid: 836cb5a8-3e14-4db6-9042-5bd4cf48a790
assay: cell viability assay
organ:
ageUnit:
species: Homo sapiens
studyId: syn27761862
cellType: Meningioma
comments: data represents dose response of cell lines to drug treatment (expressed as % viability) in drug treated cells compared to DMSO control treatment
dataType: drug screen
entityId: syn30384721
platform: EnVision 2103 Multiplate Reader
Component: PlateBasedReporterAssayTemplate
aliquotID:
diagnosis:
studyName: Leveraging Synodos NF2 data to test novel single and combination drugs in NF2-deficient meningioma models
tumorType: Meningioma
initiative: Drug Discovery Initiative Registered Reports
isCellLine: No
specimenID:
dataSubtype: processed
nf2Genotype: -/-
reporterGene:
resourceType: experimentalData
fundingAgency: CTF
isPrimaryCell: Yes
timePointUnit: hours
platformTarget:
parentSpecimenID:
reporterSubstance:
progressReportNumber: 10
experimentalCondition: drug treated vs DMSO
experimentalTimepoint: 72
specimenPreparationMethod:

NF2-_MN621 drug treatment.xlsx page is loading…